Efficacy News and Research

RSS
HHS awards SwRI $4.4M contract to develop nasal system for treating cyanide poisoning

HHS awards SwRI $4.4M contract to develop nasal system for treating cyanide poisoning

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

DARA's KRN5500 meets primary end-points in Phase II study for chemotherapy-induced neuropathic pain

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes

ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

Linagliptin demonstrates durable reductions in blood glucose for T2D adults

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

U.S. HIV/AIDS policy and funding should be guided by science, policy statement recommends

Experimental malaria vaccine shows positive results among children in small Burkina Faso study

Experimental malaria vaccine shows positive results among children in small Burkina Faso study

Scientists uncover unknown fail-safe pathway for inherited disorders

Scientists uncover unknown fail-safe pathway for inherited disorders

Azithromycin gel may treat borreliosis in humans

Azithromycin gel may treat borreliosis in humans

Diclofenac in nano-formulated doses provides effective pain relief

Diclofenac in nano-formulated doses provides effective pain relief

Hypnosis to tackle problems of chronic pain: International expert

Hypnosis to tackle problems of chronic pain: International expert

International patient groups anxiously await start of Huntington’s trial

International patient groups anxiously await start of Huntington’s trial

Cempra's solithromycin demonstrates efficacy comparable to levofloxacin for CABP treatment

Cempra's solithromycin demonstrates efficacy comparable to levofloxacin for CABP treatment

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload

First effective blood-stage vaccine against malaria

First effective blood-stage vaccine against malaria

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

SARcode Bioscience initiates enrollment in SAR 1118 Phase 3 study for dry eye disease

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

Enrollment commences in ConjuChem's CJC-1134-PC Phase 2 trial for Type 2 diabetes

New Zealand biotechnology company moves to US

New Zealand biotechnology company moves to US

Researchers may have solved 100-year-old puzzle to safely open and close the blood-brain barrier

Researchers may have solved 100-year-old puzzle to safely open and close the blood-brain barrier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.